Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 0378-0094

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0378-0094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 25 mg/100 mg Bottle Label (Image 01)

This is a medication description for a drug called "Carbidopa and Levodopa Extended-Release". Each tablet contains a combination of carbidopa and levodopa. The drug comes in a tightly sealed, light-resistant container. The text also includes dosage information indicating there are 100 tablets in the container. It appears to be manufactured by Mylan Pharmaceuticals.*

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 50 mg/200 mg Bottle Label (Image 02)

This is a medication package for Carbidopa and Levodopa Extended-Release Tablets, USP. It contains 100 tablets of 50 mg/ dose. The medication is resistant to moisture and acts as a disease inhibitor. The container should be kept closed and out of the reach of children, and stored at a temperature of 25°C. The prescription details are provided by the manufacturer Mylan Pharmaceuticals, which is located in Morgantown, WY in the United States.*

FDA Label Image

Carbidopa Structural Formula (Image 03)

FDA Label Image

Levodopa Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.